©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
The High Activity of Rat Glutathione Transferase 88 with Alkene Substrates Is Dependent on a Glycine Residue in the Active Site (*)

(Received for publication, July 3, 1995; and in revised form, September 6, 1995)

Robert Björnestedt (§) Stefania Tardioli (¶) Bengt Mannervik (**)

From the Department of Biochemistry, Uppsala University, Biomedical Center, Box 576, S-751 23 Uppsala, Sweden

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Rat glutathione transferase (GST) 8-8 displays high catalytic activity with alpha,beta-unsaturated carbonyl compounds, including lipid peroxidation products such as 4-hydroxyalkenals. The catalytic efficiency of the related class Alpha GST 1-1 is substantially lower with the same substrates. Chimeric enzymes were prepared by replacing N-terminal subunit 8 segments of different lengths (6, 25, or 100 residues) with corresponding sequences from subunit 1 using recombinant DNA techniques. The chimeric subunit r1(25)r8, containing 25 amino acid residues from subunit 1, had the same low activity with alkenal substrates as that displayed by subunit 1. Mutation of Ala-12 into Gly in r1(25)r8 gave rise to the high alkenal activity characteristic of subunit 8, showing the importance of amino acid residue 12 for the activity. However, other structural determinants are also essential, as demonstrated by the corresponding Ala-12 Gly mutation in subunit 1, which did not afford high alkenal activity. The results show that a single point mutation in a GST subunit may give rise to a 100-fold increase in catalytic efficiency with certain substrates. Introduction of such mutations may have contributed to the biological evolution of GST isoenzymes with altered substrate specificities and may also find use in the engineering of GSTs for novel functions.


INTRODUCTION

The cytosolic glutathione transferases (GSTs) (^1)are homologous proteins that have been divided into four distinct structural classes (Mannervik et al., 1985; Meyer et al., 1991). Members of a given class usually have amino acid sequence identities >70%, whereas isoenzymes of different classes have sequence identities <35% (Mannervik and Danielson, 1988). Crystal structures of members of classes Alpha (Sinning et al., 1993), Mu (Ji et al., 1992; Raghunathan et al., 1994), and Pi (Reinemer et al., 1991, 1992; Dirr et al., 1994; García-Sáez et al., 1994) have been determined, and the similarities in protein fold among members from the different classes as well as the differences in the detailed topography of the secondary structures are fully consistent with the view that the GST classes are branches on a common evolutionary tree (Mannervik, 1985).

Attempts have been made to classify glutathione transferases on the basis of activities with different substrates (Boyland and Chasseaud, 1969), but in general substrate specificities are largely overlapping, and members within the same structural class can diverge very significantly in their substrate preferences. For example, the human class Alpha enzymes GST A1-1 and GST A2-2 differ only in 11 out of the 222 amino acids encoded per subunit (Lai et al., 1984). Only four of the variant amino acids are located at the active site (Sinning et al., 1993). These limited structural differences appear to govern the significant differences in substrate specificities reported (Chow et al., 1988; Burgess et al., 1989).

In the rat, a class Alpha isoenzyme, GST 8-8, has been identified, which is characterized by particularly high catalytic activity with 4-hydroxyalkenals (Jensson et al., 1986) and other activated alkenes (Stenberg et al., 1992). The substrates include many highly cytotoxic alpha,beta-unsaturated carbonyl compounds produced by lipid peroxidation, radical reactions, and other processes elicited by oxidative stress (Berhane et al., 1994). In terms of protein design as well as from the evolutionary viewpoint, it is of interest to elucidate the structural basis for the high catalytic activity of GST 8-8 with these pathophysiologically important substrates. We have previously demonstrated that fully functional chimeric GSTs can be constructed by replacing the C-terminal one-third of a human GST structure with the corresponding segment of a rat GST (Mannervik et al., 1990; Björnestedt et al., 1992). In the present investigation it was therefore decided to construct chimeric GSTs from segments of rat GST 8-8 and rat GST 1-1 in an attempt to locate amino acid residues essential for the high catalytic activity with alkene substrates. GST 1-1 is a class Alpha enzyme that is 59% sequence identical with GST 8-8 (Stenberg et al., 1992). Its catalytic activity with long chain 4-hydroxyalkenals is 1 order of magnitude lower than that of GST 8-8, but the catalytic efficiency of GST 1-1 is still 1 order of magnitude higher than the other rat GSTs investigated (Danielson et al., 1987). The results of the present investigation show that the characteristic high catalytic efficiency of GST 8-8 with activated alkenes is critically dependent on Gly-12 in the active-site region.


MATERIALS AND METHODS

Construction of an Expression Plasmid for GST r1(100)r8

Expression vectors for the chimeric GSTs were prepared by taking advantage of unique restriction sites, either naturally present in the cDNA or introduced by specific primers, and the polymerase chain reaction (PCR). The expression plasmid for rat class Alpha subunit 1, pKRA1 (Björnestedt et al., 1992) was digested with BglII and SalI to remove 366 base pairs of the 3`-end coding region of the cDNA. The corresponding DNA segment in pKGTRA8 (Stenberg et al., 1992) coding for amino acids 101-222 of rat class Alpha subunit 8, was amplified using PCR. The primers used (synthesized at Operon Technologies Inc. Alameda, CA) had ends compatible with the BglII-SalI-digested pKRA1 vector (forward primer, 5`-CCA AGA TCT GAT GAT GAT GAT TATC-3`; reverse primer, 5`-AAGTCGAC(T)-3`). The conditions for PCR were as follows: 0.2 mM dNTPs, 1.5 mM MgCl(2), 1 µM of each primer, and 2.5 units of Taq polymerase. Temperature cycle was as follows: 1 min at 95 °C, 2 min at 54 °C, and 3 min at 72 °C repeated 30 times. After cloning of the amplified fragment into pKRA1 to give pKR1(100)R8, the construct was verified by dideoxy sequencing (Sanger et al., 1977).

Construction of an Expression Plasmid for GST r1(25)r8

A restriction site (PstI) already present in the rat subunit 1 cDNA was introduced into the corresponding position in the rat subunit 8 cDNA by PCR. This restriction site was then used as the fusion point for the two cDNA segments to give pKR1(25)R8 (forward primer, 5`-GGC TGC AGC TGG AGT GGA GTTT; reverse primer, 5`-AAGTCGAC(T)-3`).

Construction of an Expression Plasmid for GST r1(6)r8

The expression vector for GST r1(6)r8 was assembled by replacing the first 12 codons in pKGTRA8 with synthetic oligonucleotides containing the six 5`-terminal codons of the subunit 1 cDNA. A DNA fragment encoding amino acids 13-222 of rat subunit 8 was generated by PCR using pKGTRA8 as template. The reverse oligo(dT) primer, described above, was used together with a forward primer, containing EcoRI and EclXI restriction sites, for the amplification (forward, 5`-TTG AAT TCG CGG CCG TAT GGA GTC GATC-3`). The resulting DNA fragment was cloned into the EcoRI-SacI sites of M13mp18 (Boehringer). Two partially overlapping linkers (5`-TTG AAT TCA TGT CTG GGA AGC CAG TGC TT-3`) and (5`-AAC GGC CGC GGC CCT GGA AGT AGT AAA GCA CTG-3`) were annealed and extended by Sequenase (Amersham Corp.). The resulting double-stranded DNA fragment, encoding the missing N-terminal 12 amino acids, was cloned between EcoRI and EclXI restriction sites of the M13 construct containing the truncated r8 cDNA, resulting in M13mpr1(6)r8. The complete unit, coding for r1(6)r8, was then transferred from M13mpr1(6)r8 and cloned downstream of the inducible tac promoter in the expression plasmid pKK223-3 (Pharmacia Biotech Inc.) to give the expression vector pKR1(6)R8.

Construction of GST r1(25)r8 H8Y and N11Q

Single-stranded DNA of a M13mp19 clone with the expression unit (tac promoter and coding sequence) of pKR1(25)R8 was used as a template for site-directed mutagenesis by the method of Taylor et al. (1985) with specific oligonucleotides (H8Y, 5`-ATT GAA GTA GXA AAG CAC TGG-3`; N11Q, 5`-CTG GCC CGG GCY TSG AAG TAGT-3`, where X corresponds to A or T; S to G or C; and Y to C or T). The clones with the desired mutations were cloned between the BamHI and SacI restriction sites in pGEM 3Z f(+) (Promega Corp.).

Construction of GST 1-1 A12G and GST r1(25)r8 A12G

PCR was used to create the A12G mutation in pKRA1 and pKR1(25)R8 by using a forward primer containing the Ala Gly substitution (5`-TTT TTG AAT TCA TGT CTG GGA AGC CAG TGC TTC ACT ACT TCA ATG GTC GGG GCA GAA TG-3`) and reverse primers directed to pKRA1 and pKR1(25)R8, respectively.

Optimization of GST 8-8 Protein Expression

Random silent mutations were introduced into the 5` coding region of rat GST subunit 8 cDNA to introduce codons preferentially used by Escherichia coli in order to optimize the translational efficiency of GST 8-8. A primer was designed in which the last bases in five of the first 15 codons were degenerated (5`-TTT TTG AAT TCA TGG AAG TTA AAC CGA ARC TGT ACT ACT TCC ARG GCC GYG GYC GYA TGG AGT CGA TC-3`, where R corresponds to A or G). The original cDNA encoding rat GST subunit 8 was amplified using this primer and subcloned into the expression plasmid pKKD, which is a derivative of pKK223-3 (Björnestedt et al., 1992). Immunoscreening of colonies after transformation of E. coli XL1-Blue (Stratagene, La Jolla, CA) identified a clone (pEXRA8) that expressed rat GST 8-8 in high yield. The following sequence was found in the 5`-end of pEXRA8: ATG GAA GTT AAA CCG AAA CTG TAC TAC TTC CAG GGC CGT GGC CGT ATG.

Protein Expression and Purification

The recombinant wild-type and mutant enzymes were expressed in E. coli XL1-Blue and purified using glutathione-Sepharose (Simons and Vander Jagt, 1977) essentially as described previously (Widersten et al., 1991).

Assays for Determination of Kinetic Properties

The steady-state kinetics were studied spectrophotometrically in 0.1 M sodium phosphate, 1 mM EDTA, pH 6.5, 30 °C. The assay conditions for the different substrates have been published (Mannervik and Widersten, 1995). The specificity constants, k/K(m), were determined with 1 mM GSH and low concentrations of the electrophile (typically 10-20 µM) and were calculated from k/K(m) = v/[E]bullet[S].


RESULTS

Expression and Purification of Chimeric and Mutant GSTs

A series of chimeras was constructed from the parental GST 1-1 and GST 8-8 to probe segments of the primary structure as determinants for specificity and catalytic efficiency toward alpha,beta-unsaturated carbonyl compounds. Three such chimeras, r1(6)r8, r1(25)r8, and r1(100)r8, were obtained in which 3, 11, and 45%, respectively, of the sequence beginning from the N terminus is derived from subunit 1 and the remainder up to the C terminus is derived from subunit 8; the number within parentheses denotes the amino acid residue at the fusion point between the two segments; ``r'' is used to distinguish rat sequences from human sequences in chimeric constructs (cf. Björnestedt et al.(1992)). The amino acid substitutions afforded by the construction of the chimeras appear by comparing the parental subunits (Fig. 1). The chimera r1(25)r8 was also subjected to site-directed mutagenesis, to make it more similar to GST 8-8, in order to assess the contribution of single amino acids (H8Y, N11Q, and A12G) to catalysis and to binding of the electrophilic substrate.


Figure 1: Amino acid sequences of GST subunits 1 and 8. Positions of identity between the sequences are indicated by dashes. The initiator methionine is missing in the recombinant subunit 1, but it is retained in subunit 8. Fusion points for chimeric structures involving an N-terminal segment of subunit 1 and the remainder to the C terminus from subunit 8 are indicated by vertical arrows. The glutathione-binding (G-site) residues are indicated by g, and the second-substrate binding (H-site) residues are indicated by h below the sequences, based on comparison with the human class Alpha subunit A1 structure (Sinning et al., 1993). The exons of the corresponding genomic DNA, determined for subunit 1 (Telakowski-Hopkins et al., 1986), are shown below the sequences.



All of the chimeric and mutant enzymes displayed affinity for the glutathione affinity matrix used in the purification, indicating that the glutathione-binding site was functional. GST r1(6)r8, r1(25)r8, and all other variant forms were catalytically active, expressed in moderate to high yields, and appeared to be stable in the pure state. However, GST r1(100)r8 was unstable and obtained in low yield. It is worth noting that the base composition in the 5` coding end strongly affected the expression levels of the proteins. For example, GST r1(25)r8 N11Q was obtained in 10-fold higher yield than GST r1(25)r8, as a result of substituting two bases in codon 11. This dependence on optimal codons at the beginning of the mRNA was utilized to increase the expression levels of GST 8-8 in a rational way. Five codons in the 5` coding region of the subunit 8 cDNA, which are rarely present in highly biased genes in E. coli (Andersson and Kurland, 1990), were selected for silent random mutagenesis. Thus, a library of expression vectors was created with the goal of improving the protein expression level. This successful approach led to the isolation of a clone capable of expressing GST 8-8 at 25-fold increased level compared with the previously published pKGTRA8 (Stenberg et al., 1992).

N-terminal amino acid sequence analysis of GST r1(25)r8 A12G confirmed the expected primary structure SGKPVLHYFNGRGRMECI. Likewise, in the heterologously expressed GST 1-1, the initiator Met is removed by the E. coli Met aminopeptidase, leaving a Ser as the N-terminal residue of the recombinant protein (Wang et al., 1989). In contrast, the N-terminal Met is retained in GST 8-8 (Stenberg et al., 1992), as expected for a sequence with Glu as the penultimate amino acid residue (Dalbøge et al., 1990).

Kinetic Characterization of Chimeric GSTs

Table 1shows the specificity constants (k/K(m)) obtained under steady-state conditions for GSTs 1-1 and 8-8 as well as for all mutant forms with five different substrates. The substrates chosen for the analysis were those for which distinct differences in catalytic activity have been established between GSTs 1-1 and 8-8 (Mannervik and Danielson, 1988). The k/K(m) values for the mutant GST 1-1 A12G were indistinguishable from those of wild-type GST 1-1 with all substrates tested, whereas GST r1(6)r8 displayed the properties of GST 8-8. All other variant GSTs showed specificity constants toward CDNB that were similar to those of GST 8-8, which is 16-fold lower than that of GST 1-1. The catalytic efficiencies of GST r1(25)r8 and its H8Y and N11Q mutants, measured with the substrates containing alpha,beta-unsaturated functional groups, fell between the extremes of the values for the two parental enzymes. In contrast, GST r1(25)r8 A12G, which only differs from GST r1(25)r8 in lacking a methyl group in position 12, was essentially as efficient as GST 8-8 in catalyzing Michael additions with the four alpha,beta-unsaturated carbonyl compounds tested.




DISCUSSION

Earlier investigations have shown that rat class Alpha GST 8-8 is much more efficient than GST 1-1 in inactivating 4-hydroxyalkenals by catalyzing their conjugation with glutathione (Danielson et al., 1987). Although the sequence identity between GST 1-1 and GST 8-8 is only 59% (Fig. 1), indirect evidence for heterodimer formation has been reported (Johnson et al., 1990). Also, the overall fold is assumed to be similar for isoenzymes belonging to the same structural class. The inherent substrate diversity (GST 8-8 is more than 100-fold more active with 4-hydroxypentenal than is GST 1-1) in combination with structural similarities make GST 1-1 and GST 8-8 an ideal pair for the construction of functional chimeras with the goal of elucidating the structural basis for function.

The chimeric GST r1(25)r8, in which the N-terminal segment of 25 amino acid residues of subunit 8 have been replaced, is altered in nine positions as compared with GST 8-8 (Fig. 1). The four substitutions closest to the N terminus of these nine alterations, caused no or little effect on the catalytic behavior as demonstrated by the characteristics of the chimeric GST r1(6)r8. When three of the remaining five variant residues were subjected to site-directed mutagenesis, the H8Y and N11Q alterations caused only modest effects on the catalytic efficiency toward alpha,beta-unsaturated carbonyl compounds. As judged by comparison with the three-dimensional structure of the homologous human class Alpha GST A1-1 (Sinning et al., 1993), residues 18 and 25 are far removed from the active site and were therefore not mutated. However, the A12G substitution in GST r1(25)r8 essentially restored the catalytic properties of GST 8-8. The effect of the mutation was reflected in a DeltaDeltaG value of 10 kJ/mol of incremental transition state stabilization (calculated from the k/K(m) values, cf. Danielson et al., 1987) when monitored with 4-hydroxynonenal for GST r1(25)r8 A12G as compared with GST 1-1. In contrast, only 0.3 and 0.8 kJ/mol were calculated for GST 1-1 A12G and GST r1(25)r8, respectively, as compared with GST 1-1, showing that the effect of the A12G mutation is dependent on the structural context.

Based on the three-dimensional structure of human GST A1-1 (Sinning et al., 1993), which is the human enzyme most similar to rat GST 1-1, Ala in position 12 is one of the residues forming the active site. However, it is situated approximately 9 Å from the sulfur of enzyme-bound glutathione and 9 Å from the electrophilic group of the second substrate, which reacts with the sulfur in the catalyzed reaction. Assuming that the overall architecture of the active sites of GST 1-1 and GST 8-8 is similar to that of human GST A1-1, residue 12 is probably not in direct contact with either GSH or the electrophilic substrate, but mediates its effect via interactions with other structural elements that contribute to the active site. Gly allows greater variation in the conformation of the polypeptide chain than do other amino acid residues (Creighton, 1993) and may induce changes in the topology of the active site when it replaces Ala.

The second-substrate binding site, or H-site, in human GST A1-1 is highly hydrophobic, a property that appears to be preserved in both GST 1-1 and GST 8-8. However, 9 of the approximately 15 amino acids that contribute to the H-site differ between GST 1-1 and GST 8-8 (Table 2). A larger substrate-binding cavity in GST 8-8, corresponding to approximately five methyl groups, can be calculated from the volume enclosed by the van der Waals radii of the 9 residues differing in the H-site between subunit 1 and 8 (Creighton, 1993). However, this approximate calculation does not consider possible structural readjustments induced by the amino acid substitutions in the active site.



Comparison of class Alpha primary structures reveals that mouse GST A4-4 (Zimniak et al., 1992), human GST 5.8 (Singhal et al., 1994a), chicken GST CL3 (Chang et al., 1992), and rat GST 8-8 form a distinct subgroup within the Alpha class (Singhal et al., 1994b). For example, the amino acid sequence of rat GST 8-8 is 91% identical to that of mouse GST A4-4. All GSTs from this subgroup are highly active with 4-hydroxynonenal with some uncertainty for GST CL3, which has not been assayed with this substrate.

It is clear from the properties of the GST 1-1 Ala-12 Gly mutant that the Ala-12 Gly substitution alone in the GST subunit 1 framework cannot confer the high alkenal activity exhibited by GST 8-8 onto GST 1-1. Contributions by other residues, yet to be defined, are also needed. A closer examination of postulated H-site residues within the subgroup of sequence-related isoenzymes with high 4-hydroxyalkenal activity reveals that Gly-12, Pro-110, Phe-111, Val-213, Val-216, and Leu-220 are conserved, whereas other residues are variable (Table 2). Further experiments are needed to clarify whether or not it would be possible to redesign the active site of GST 1-1 by substitution of a limited number of residues in the H-site to mimic the substrate profile of GST 8-8.

It is also noteworthy that the residue in position 12 is 1 out of the 11 amino acids that differ between the human isoenzymes GST A1-1 and GST A2-2 (Table 2), which show divergent substrate specificities (Chow et al., 1988; Burgess et al., 1989). Furthermore, the amino acid at the topologically equivalent position in two class Mu isoenzymes has been suggested as a determinant for stereoselectivity toward alpha,beta-unsaturated ketones (Zhang et al., 1992; Shan and Armstrong, 1994). Van Ness et al. (1994) have constructed chimeric GSTs in an attempt to identify the contribution of three different regions of a mouse enzyme to the high activity with the hepatocarcinogen aflatoxin B(1) 8,9-epoxide. However, the specific residues of importance for the substrate selectivity were not identified.

This investigation complements previous studies showing that construction of chimeric GSTs is a feasible approach to modular design of new functional entities (Zhang and Armstrong, 1990; Mannervik et al., 1990; Zhang et al., 1992; Björnestedt et al., 1992; Van Ness et al., 1994). The positive outcome of these experiments lends support to the proposal that recombination of segments of genomic DNA may have been an evolutionary mechanism for generation of novel GST isoenzymes (Mannervik, 1985). The chimera r1(25)r8 corresponds to the product that would result from a switching from the gene for subunit 1 to the gene for subunit 8 in a position between exons 2 and 3 (residues 26-29 are identical between the subunits, cf. Fig. 1).

GSTs are capable of interacting with a very broad range of molecular structures (Mannervik and Danielson, 1988) and have attractive features for protein engineering, including high yield expression in E. coli and lack of post-translational modifications. It should be possible to redesign GSTs to obtain catalysts for GSH conjugation of a very broad range of electrophilic compounds by optimizing the active site structure of the enzyme for the particular reaction to be catalyzed. This has recently been attempted via selection of GST mutants by use of phage display (Widersten and Mannervik, 1995; Mannervik et al., 1995). Conventional wisdom in the field of detoxication enzymes maintains that such enzymes have low catalytic efficiencies in order to be able to react with a broad range of substrates (Jakoby, 1980). According to this paradigm, it would appear difficult to obtain mutant enzymes with high catalytic turnover. However, the present work shows that high catalytic efficiency can be obtained by a single point mutation to give a variant GST, i.e. r1(25)r8 Ala-12 Gly, with high catalytic efficiency not only in relative terms, but also on an absolute scale (k/K(m) > 10^6M s).


FOOTNOTES

*
This work was supported by the Swedish Natural Science Research Council, the Swedish Research Council for Engineering Sciences, and the National Board for Industrial and Technical Development. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Recipient of a fellowship from Sven and Lilly Lawski's Fund.

Supported by the Italian Culture Institute ``C. M. Lerici'' in Stockholm.

**
To whom correspondence should be addressed. Tel.: 46-18-174535; Fax: 46-18-558431.

(^1)
The abbreviations used are: GST, glutatione transferase; PCR, polymerase chain reaction; CDNB, 1-chloro-2,4-dinitrobenzene.


ACKNOWLEDGEMENTS

We thank Professor Hermann Esterbauer, University of Graz, Graz, Austria for generously providing 4-hydroxyalkenals for our studies and Dr. Mikael Widersten in our laboratory for valuable discussions. Dr. Åke Engström, Uppsala University, kindly performed the amino acid sequence analysis.


REFERENCES

  1. Andersson, S. G. E., and Kurland, C. G. (1990) Microbiol. Rev. 54, 198-210
  2. Berhane, K., Widersten, M., Engström, Å., Kozarich, J. W., and Mannervik, B. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 1480-1484 [Abstract]
  3. Björnestedt, R., Widersten, M., Board, P. G., and Mannervik, B. (1992) Biochem. J. 282, 505-510 [Medline] [Order article via Infotrieve]
  4. Board, P. G., and Webb, G. C. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 2377-2381 [Abstract]
  5. Boyland, E., and Chasseaud, L. F. (1969) Adv. Enzymol. 32, 173-219 [Medline] [Order article via Infotrieve]
  6. Burgess, J. R., Chow, N.-W. I., Reddy, C. C., and Tu, C.-P. D. (1989) Biochem. Biophys. Res. Commun. 158, 497-502 [Medline] [Order article via Infotrieve]
  7. Chang, L.-H., Fan, J.-Y., Liu, L.-F., Tsai, S.-P., and Tam, M. F. (1992) Biochem. J. 281, 545-551 [Medline] [Order article via Infotrieve]
  8. Chow, N.-W. I., Whang-Peng, J., Kao-Shan, C.-S., Tam, M. F., Lai, H.-C. J., and Tu, C.-P. D. (1988) J. Biol. Chem. 263, 12797-12800 [Abstract/Free Full Text]
  9. Creighton, T. E. (1993) Proteins: Structures and Molecular Properties , 2nd Ed., pp. 1-20, W. H. Freeman & Co., New York
  10. Dalbøge, H., Bayne, S., and Pedersen, J. (1990) FEBS Lett. 266, 1-3 [CrossRef][Medline] [Order article via Infotrieve]
  11. Danielson, U. H., Esterbauer, H., and Mannervik, B. (1987) Biochem. J. 247, 707-713 [Medline] [Order article via Infotrieve]
  12. Dirr, H., Reinemer, P., and Huber, R. (1994) J. Mol. Biol. 243, 72-92 [CrossRef][Medline] [Order article via Infotrieve]
  13. García-Sáez, I., Párraga, A., Phillips, M. F., Mantle, T. J., and Coll, M. (1994) J. Mol. Biol. 237, 298-314 [CrossRef][Medline] [Order article via Infotrieve]
  14. Jakoby, W. B. (1980) in Enzymatic Basis of Detoxication (Jakoby, W. B., ed) Vol. 1, pp. 1-6, Academic Press, New York _
  15. Jensson, H., Guthenberg, C., Ålin, P., and Mannervik, B. (1986) FEBS Lett. 203, 207-209 [CrossRef][Medline] [Order article via Infotrieve]
  16. Ji, X., Zhang, P., Armstrong, R. N., and Gilliland, G. L. (1992) Biochemistry 31, 10169-10184 [Medline] [Order article via Infotrieve]
  17. Johnson, J. A., Neal, T. L., Collins, J. H., and Siegel, F. L. (1990) Biochem. J. 270, 483-489 [Medline] [Order article via Infotrieve]
  18. Lai, H.-C. J., Li, N., Weiss, M. J., Reddy, C. C., and Tu, C.-P. D. (1984) J. Biol. Chem. 259, 5536-5542 [Abstract/Free Full Text]
  19. Mannervik, B. (1985) Adv. Enzymol. Relat. Areas Mol. Biol. 57, 357-417 [Medline] [Order article via Infotrieve]
  20. Mannervik, B., and Danielson, U. H. (1988) CRC Crit. Rev. Biochem. 23, 283-337 [Medline] [Order article via Infotrieve]
  21. Mannervik, B., and Widersten, M. (1995) in Advances in Drug Metabolism in Man (Pacifici, G. M., and Fracchia, G. N., eds) pp. 407-459, European Commission, Luxembourg
  22. Mannervik, B., Ålin, P., Guthenberg, C., Jensson, H., Tahir, M. K., Warholm, M., and Jörnvall, H. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 7202-7206 [Abstract]
  23. Mannervik, B., Board, P. G., Berhane, K., Bj ö rnestedt, R., Castro, V. M., Danielson, U. H., Hao, X.-Y., Kolm, R., Olin, B., Principato, G. B., Ridderstr ö m, M., Stenberg, G., and Widersten, M. (1990) in Glutathione S-Transferases and Drug Resistance (Hayes, J. D., Pickett, C. B., and Mantle, T. J., eds) pp. 35-46, Taylor and Francis, London
  24. Mannervik, B., Widersten, M., Bj ö rnestedt, R., and Hansson, L. O. (1995) in Perspectives on Protein Engineering (Geisow, M. J., and Epton, R., eds) pp. 138-142, Mayflower Worldwide Ltd., Wolverhampton, United Kingdom
  25. Meyer, D. J., Coles, B., Pemble, S. E., Gilmore, K. S., Fraser, G. M., and Ketterer, B. (1991) Biochem. J. 274, 409-414 [Medline] [Order article via Infotrieve]
  26. Pickett, C. B., Telakowski-Hopkins, C. A., Ding, G. J.-F., Argenbright, L., and Lu, A. Y. H. (1984) J. Biol. Chem. 259, 5182-5188 [Abstract/Free Full Text]
  27. Raghunathan, S., Chandross, R. J., Kretsinger, R. H., Allison, T. J., Penington, C. J., and Rule, G. S. (1994) J. Mol. Biol. 238, 815-832 [CrossRef][Medline] [Order article via Infotrieve]
  28. Reinemer, P., Dirr, H. W., Ladenstein, R., Schäffer, J., Gallay, O., and Huber, R. (1991) EMBO J. 10, 1997-2005 [Abstract]
  29. Reinemer, P., Dirr, H. W., Ladenstein, R., and Huber, R. (1992) J. Mol. Biol. 227, 214-226 [Medline] [Order article via Infotrieve]
  30. Rhoads, D. M., Zarlengo, R. P., and Tu, C.-P. D. (1987) Biochem. Biophys. Res. Commun. 145, 474-481 [Medline] [Order article via Infotrieve]
  31. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467 [Abstract]
  32. Shan, S., and Armstrong, R. N. (1994) J. Biol. Chem. 269, 32373-32379 [Abstract/Free Full Text]
  33. Simons, P. C., and Vander Jagt, D. L. (1977) Anal. Biochem. 82, 334-341 [Medline] [Order article via Infotrieve]
  34. Singhal, S. S., Zimniak, P., Sharma, R., Srivastava, S. K., Awasthi, S., and Awasthi, Y. C. (1994a) Biochim. Biophys. Acta 1204, 279-286 [Medline] [Order article via Infotrieve]
  35. Singhal, S. S., Zimniak, P., Awasthi, S., Piper, J. T., He, N.-G., Teng, J. I., Petersen, D. R., and Awasthi, Y. C. (1994b) Arch. Biochem. Biophys. 311, 242-250 [CrossRef][Medline] [Order article via Infotrieve]
  36. Sinning, I., Kleywegt, G. J., Cowan, S. W., Reinemer, P., Dirr, H. W., Huber, R., Gilliland, G. L., Armstrong, R. N., Ji, X., Board, P. G., Olin, B., Mannervik, B., and Jones, T. A. (1993) J. Mol. Biol. 232, 192-212 [CrossRef][Medline] [Order article via Infotrieve]
  37. Stenberg, G., Ridderström, M., Engström, Å., Pemble, S. E., and Mannervik, B. (1992) Biochem. J. 284, 313-319 [Medline] [Order article via Infotrieve]
  38. Taylor, J. W., Ott, J., and Eckstein, F. (1985) Nucleic Acids Res. 13, 8765-8785 [Abstract]
  39. Telakowski-Hopkins, C. A., Rothkopf, G. S., and Pickett, C. B. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 9393-9397 [Abstract]
  40. Tu, C.-P. D., and Qian, B. (1986) Biochem. Biophys. Res. Commun. 141, 229-237 [Medline] [Order article via Infotrieve]
  41. Van Ness, K. P., Buetler, T. M., and Eaton, D. L. (1994) Cancer Res. 54, 4573-4575 [Abstract]
  42. Wang, R. W., Pickett, C. B., and Lu, A. Y. H. (1989) Arch. Biochem. Biophys. 269, 536-543 [Medline] [Order article via Infotrieve]
  43. Widersten, M., and Mannervik, B. (1995) J. Mol. Biol. 250, 115-122 [CrossRef][Medline] [Order article via Infotrieve]
  44. Widersten, M., Pearson, W. R., Engström, Å., and Mannervik, B. (1991) Biochem. J. 276, 519-524 [Medline] [Order article via Infotrieve]
  45. Zhang, P., and Armstrong, R. N. (1990) Biopolymers 29, 159-169 [Medline] [Order article via Infotrieve]
  46. Zhang, P., Liu, S., Shan, S., Ji, X., Gilliland, G. L., and Armstrong, R. N. (1992) Biochemistry 31, 10185-10193 [Medline] [Order article via Infotrieve]
  47. Zimniak, P., Eckles, M. A., Saxena, M., and Awasthi, Y. C. (1992) FEBS Lett. 313, 173-176 [CrossRef][Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.